Dr. Saad Usmani reports on the clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.
Advertisement
Advertisement
[the_ad id="32629"]
ASH 2015: Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated RRMM
By Editor